13
Views
12
CrossRef citations to date
0
Altmetric
Review

Chemoprotective potential of phase 2 enzyme inducers

&
Pages 581-592 | Published online: 10 Jan 2014

References

  • Greenlee RT, Murray T, Bolden S et al Cancer statistics, 2000. CA Cancerj Clin. 50, 7–33 (2000).
  • Bailar JC, 3rd, Gornik HL. Cancer undefeated. N Engl. I Med. 336, 1569–1574 (1997).
  • Hawk ET, Lippman SM. Primary cancer prevention trials. Hematol Oncol Gun. N Am. 14, 809–830 (2000).
  • Sporn MB, Suh N. Chemoprevention of cancer. Catrinogenesis21, 525–530 (2000).
  • Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 278, 1073–1077 (1997).
  • Kelloff GJ, Crowell JA, Steele VE et al Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. Nut': 130, 467S-471S (2000).
  • Hill DL, Grubbs CJ. Retinoids and cancer prevention. Ann. Rev Nutt: 12, 161–181 (1992).
  • Schwartz AG, Pashko LL. Cancer prevention with dehydroepiandrosterone and non-androgenic structural analogs. Cell Biochem. Suppl 22, 210–217 (1995).
  • Dhingra K. Selective estrogen receptor modulation: the search for an ideal hormonal therapy for breast cancer. Cancer Invest 19, 649–659 (2001).
  • Miller EC, Miller JA. Some historical perspectives on the metabolism of xenobiotic chemicals to reactive intermediates. In: Bioactivation of Fomign Compound. Anders MW (Ed.), New York: Academic Press, New York, NY, USA, 1–28 (1985).
  • Klaassen CD. Casated and DouUi Toxicology McGraw-Hill, New York, NY, USA, (1996).
  • Hayes JD, Pulford DJ. The glutathione 5- transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Grit. Rev. Biochem. Mal Biol. 30, 445–600 (1995).
  • Primiano T, Gastel JA, Kensler TVV et al Isolation of cDNAs representing dithiolethione-responsive genes. Catrinogenesis 17, 2297–2303 (1996).
  • Marnett U. Oxyradicals and DNA damage. Catrinogenesis 21, 361–370 (2000).
  • Forsberg L, de Faire U, Morgenstern R. Oxidative stress, human genetic variation and disease. Arch. Biochem. Biophys 389, 84–93 (2001).
  • Dick RA, Kwak MK, Sutter TR et al. Anti- oxidative function and substrate specificity of NAD(P)H dependent alkenal/one oxidoreductase: a new role for leukotriene B4 12-hydroxydehyrdogenase/15-oxoprostaglandin 13-reductase. J. Biol. Chem. 27, 27 (2001).
  • O'Connor T, Ireland LS, Harrison DJ et al. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AIKR1 family members. Biochem. 343 (Pt 2), 487–504 (1999).
  • Ross D, Kepa JK, Winski SL et al. NAD(P)H:quinone oxidoreductase 1 (NQ01): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem. Biol. Intemct. 129, 77–97 (2000).
  • Nappi AJ, Vass E. Iron, metalloenzymes and cytotoxic reactions. Cell Mal Biol. 46, 637–647 (2000).
  • Prochaska HJ, Talalay P. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res. 48, 4776–4782 (1988).
  • Talalay P, De Long MJ, Prochaska HJ. Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Pox. Nat/ Acad. Sci USA 85, 8261–8265 (1988).
  • Prestera T, Holtzclaw WD, Zhang Y et al Chemical and molecular regulation of enzymes that detoxify carcinogens. Pox. Natl Acad. Sci. USA 90, 2965–2969 (1993).
  • Wilson CL, Safe S. Mechanisms of ligand- induced aryl hydrocarbon receptor-mediated biochemical and toxic responses. Toxicol Athol 26, 657–671 (1998).
  • Sogawa K, Fujii-Kuriyama Y. Ah receptor, a novel ligand-activated transcription factor. Biochem. (7o' lryo)122, 1075–1079 (1997).
  • McMahon M, Itoh K,Yamamoto M et al The Ca Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res. 61, 3299–3307 (2001).
  • Venugopal R, Jaiswal AK. Nrfl and Nrf2 positively and c-Fos and Fral negatively regulate the human anti-oxidant response element-mediated expression of NAD(P)H:quinone oxidoreductasel gene. Proc. Natl Acad. Sci. USA 93, 14960–14965 (1996).
  • Itoh K, Chiba T, Takahashi S et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through anti-oxidant response elements. Biochem. Biophys Res. Commun. 236, 313–322 (1997).
  • •Initial description of the role of Nrf2 in phase 2 enzyme induction in viva
  • Kwak MK, Itoh K, Yamamoto M et al Role of transcription factor Nrf2 in the induction of hepatic phase 2 and anti-oxidative enzymes in Ova by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione../1/b1 Med. 7, 135–145 (2001).
  • Itoh K, Wakabayashi N, Katoh Yet al Keapl represses nuclear activation of anti-oxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13, 76–86 (1999).
  • ••Identification of the molecular sensor forinduction of phase 2 enzymes by monofuctional inducers.
  • Dinkova-Kostova AT, Massiah MA, Bozak RE et al From the cover: potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc. Natl Acad. Sci. USA 98, 3404–3409 (2001).
  • Carey IKA, Kensler TW, Fishbein JC. Kinetic constraints for the thiolysis of 4-methyl-5- (pyrazin-2 -y1) -1, 2-dithiole -3-thione (oltipraz) and related dithiole-3-thiones in aqueous solution. Chem. Res. ToxicoL 14, 939–945 (2001).
  • Bradlow HL, Michnovicz JJ, Halper M et al Long-term responses of women to indole-3-carbinol or a high fiber diet. Cancer Epidemiol Biomarkets Rev 3, 591–595 (1994).
  • Izzotti A, Camoirano A, Cartiglia C et al Patterns of DNA adduct formation in liver and mammary epithelial cells of rats treated with 7,12—dimethylbenz(a)anthracene and selective effects of chemopreventive agents. Cancer Res. 59, 4285–4290 (1999).
  • Crabtree HG. Influence of bromobenzene on the induction of skin tumors by 3,4-benzpyrene. Cancer Res. 4, 688–693 (1944).
  • Richardson HL, Cunningham L. The inhibitory action of methykholanthrene on rats fed the azo dye 3 --methy1-4-dimethyl-aminoazobenzene. Cancer Res. 11, 274–276 (1951).
  • Wattenberg LW Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by phenolic anti-oxidants and ethoxyquin. Natl Cancer Inst. 48, 1425–1430 (1972).
  • Wattenberg LW Bueding E. Inhibitory effects of 5- (2-pyrazinyl) -4-methy1-1,2-dithio1-3-thione (Oltipraz) on carcinogenesis induced by benzo[a]pyrene, diethylnitrosamine and uracil mustard. Catrinogenesis 7, 1379–1381 (1986).
  • Block G, Patterson B, Subar A. Fruit, vegetables and cancer prevention: a review of the epidemiological evidence. Nutt: Cancer18, 1–29 (1992).
  • Steinmetz IKA, Potter JD. Vegetables, fruit and cancer prevention: a review. jAm Diet Assoc. 96, 1027–1039 (1996).
  • Beecher CW Cancer preventive properties of varieties of Brassica oleracea: a review. AM. I Clin. Nutt: 59, 1166S-1170S (1994).
  • Graham S. Results of case-control studies of diet and cancer in Buffalo, New York.Cancer Res. 43, 2409s-2413s (1983).
  • Colditz GA, Branch LG, Lipnick RJ et al Increased green and yellow vegetable intake and lowered cancer deaths in an elderly population. Am. J. Clin. Nutt: 41, 32–36 (1985).
  • Prochaska HJ, Santamaria AB, Talalay Rapid detection of inducers of enzymes that protect against carcinogens.Proc. NatlAcad. Sci. USA 89, 2394–2398 (1992).
  • Kelloff GJ, Crowell JA, Hawk ET et al Clinical development plan: phenethyl isothiocyanate. J. Cell Biochem. Suppl 26, 149–157 (1996).
  • Fenwick GR, Heaney RIK, Mullin WJ. Glucosinolates and their breakdown products in food and food plants. Grit. Rev Food Sci. Nutt: 18, 123–201 (1983).
  • Zhang Y, Talalay P Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms. Cancer Res. 54, 1976–1981 (1994).
  • Sidransky H, Ito N, Verney E. Influence of a-naphthyl-isothiocyanate on liver tumorigenesis in rats ingesting ethionine and N-2-fluorenylacetamide. j Natl Cancer Inst. 37, 677–686 (1966).
  • Lacassagne A, Hurst L, Xuong MD. [Inhibition by 2 naphtylisothiocyanates of hepatocarcinogenesis induced by p-dimethylaminoazobenzene (DAB) in rats]. C R Seances Soc. Biol. Fil 164, 230–233 (1970).
  • Boyd JN, Babish JG, Stoewsand GS. Modification of beet and cabbage diets of aflatoxin B1-induced rat plasma a-foetoprotein elevation, hepatic tumorigenesis and mutagenicity of urine. Food Chem. Toxicol 20, 47–52 (1982).
  • Fahey JVV, Zhang Y, Talalay P Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc. Natl Acad. Sci. USA 94, 10367–10372 (1997).
  • •A natural soture of a very potent phase 2 enzyme inducer (sulforaphane) is identified.
  • Chung FL, Morse MA, Eklind KI et al. Quantitation of human uptake of the anticarcinogen phenethyl isothiocyanate after a watercress meal. Cancer Epidemiol Biomarker s Prey. 1, 383–388 (1992).
  • Liebes L, Conaway CC, Hochster H et al High-performance liquid chromatography-based determination of total isothiocyanate levels in human plasma: application to studies with 2-phenethyl isothiocyanate. Anal Biochem. 291, 279–289 (2001).
  • Hecht SS, Carmella SG, Murphy SE. Effects of watercress consumption on urinary metabolites of nicotine in smokers. Cancer Epidemiol Biomarker s Prey 8, 907–913 (1999).
  • •Clinical study that demonstrates that phase 2 metabolism can be elevated in humans by a naturally occurring inducer.
  • Rose P, Faulkner K, Williamson G et al 7- Methylsulfinylheptyl and 8- methylsulfinyloctyl isothiocyanates from watercress are potent inducers of phase II enzymes. Catrinogenesis 21, 1983–1988 (2000).
  • Nakajima M, Yoshida R, Shimada N et al Inhibition and inactivation of human cytochrome P450 isoforms by phenethyl isothiocyanate. Drug- Metab. Dispos 29, 1110–1103 (2001).
  • Goosen TC, Kent UM, Brand L et al. Inactivation of cytochrome P450 2B1 by benzyl isothiocyanate, a chemopreventative agent from cruciferous vegetables. Chem. Res. Toxicol 13, 1349–1359 (2000).
  • Xu K, Thornalley PJ. Involvement of glutathione metabolism in the cytotoxicity of the phenethyl isothiocyanate and its cysteine conjugate to human leukaemia cells in vitt-a Biochem. Pharmacol 61, 165–177 (2001).
  • Hecht SS. Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism. j Nutt: 129, 768S-774S (1999).
  • Hoffmann DaH. Advances in tobacco carcinogenesis. In: Handbook of Experimental Pharmacology Cooper PL (Ed.), Springer-Verlag, Heidelberg, Germany, 94, 63–102 (1990).
  • Hecht SS. Carcinogenesis due to tobacco: molecular mechanisms. In: Encyclopedia of Cancer. Academic Press, San Diego, CA, USA, 220–232 (1996).
  • Hecht SS. DNA adduct formation from tobacco-specific N-nitrosamines. Mutat. Res. 424, 127–142 (1999).
  • Hecht SS, Trushin N, Rigotty J et al. Complete inhibition of 4-(methylnitrosamino) 1 (3 pyridy0-1-butanone-induced rat lung tumorigenesis and favorable modification of biomarkers by phenethyl isothiocyanate. Cancer Epidemiol Biomarker s Rev 5, 645–652 (1996).
  • •A successful preclinical model for inhibition of lung cancer in smokers by phenethyl isothiocyanate.
  • Hecht SS, Chung FL, Richie JP, Jr. et al Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers. Cancer Epidemiol Biomarker s Prey. 4, 877–884 (1995).
  • Zhang Y, Talalay P, Cho CG et al A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc. Natl Acad. Sci. USA 89, 2399–2403 (1992).
  • Langouet S, Furge LL, Kerriguy N et al. Inhibition of human cytochrome P450 enzymes by 1,2-dithiole-3-thione, oltipraz and its derivatives and sulforaphane. Chem. Res. Toxicol 13, 245–252 (2000).
  • Barcelo S, Gardiner JM, Gescher A et al CYP2E1-mediated mechanism of antigenotoxicity of the broccoli constituent sulforaphane. Catrinogenesis 17, 277–282 (1996).
  • Shapiro TA, Fahey JVV, Wade KL et al Chemoprotective glucosinolates and isothiocyanates of broccoli sprouts: metabolism and excretion in humans. Cancer Epidemiol Biomarkers Prey. 10, 501–508 (2001).
  • •A Phase I clinical trial using broccoli sprouts as a source of sulforaphane.
  • Chung FL, Conaway CC, Rao CV et al. Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis21, 2287–2291 (2000).
  • Fahey JVV, Haristoy X, Dolan PM et al. Sulforaphane inhibits extracellular, intracellular and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc. Natl Acad. Sci. USA 99, 7610–7615 (2002).
  • Bonnesen C, Eggleston IM, Hayes JD. Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res. 61, 6120–6130 (2001).
  • Ye L, Dinkova-Kostova AT, Wade KL et al Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans. Clin. Chim. Acta. 316, 43–53 (2002).
  • Shapiro TA, Fahey JVV, Wade KL et al Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables. Cancer Epidemiol Biomarker s Prey 7, 1091–1100 (1998).
  • Jirousek L. Isolierung und identifizierung organischer polysulfide aus krolut and ihre beziehung zum Brassica faktor. Collect. Czech. Chem. Commun. 22, 1494–1502 (1957).
  • Archer S. The chemotherapy of schistosomiasis. Ann. Rev Pharmacol Toxicol 25, 485–508 (1985).
  • Bueding E, Dolan P, Leroy JR The antischistosomal activity of oltipraz. Res. Commun. Chem. Pathol Pharmacol 37, 293–303 (1982).
  • Ansher SS, Dolan P, Bueding E. Biochemical effects of dithiolthiones. Food Chem. Toxicol 24, 405–415 (1986).
  • Otieno MA, Kensler TW, Guyton KZ. Chemoprotective 3H-1,2-dithiole-3-thione induces anti-oxidant genes in vivo. Free Rad. Biol. Med. 28, 944–952 (2000).
  • Kelloff GJ, Crowell JA, Boone CW et al Clinical development plan: oltipraz. I Cell Biochem. Suppl 20, 205–218 (1994).
  • Clapper ML. Chemopreventive activity of oltipraz. Pharmacol Ther. 78, 17–27 (1998).
  • Ramos-Gomez M, Kwak MK, Dolan PM et al Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc. Natl Acad. Sc]. USA 98, 3410–3415 (2001).
  • •Use of molecular genetics to provide a link between phase 2 enzyme induction and protection from carcinogenesis.
  • Benson AB, 3rd. Oltipraz: a laboratory and clinical review. J. Cell Biochem. Suppl 278–291 (1993).
  • Gupta E, Olopade 01, Ratain MJ et al Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent. Clin Cancer Res. 1, 1133–8. (1995).
  • O'Dwyer PJ, Szarka CE, Yao KS et al Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz.j Clin. Invest. 98, 1210–1217 (1996).
  • •Direct demonstration of phase 2 enzyme induction in humans by oltipraz.
  • Benson AB, 3rd, Olopade 01, Ratain MJ et al Chronic daily low dose of 4-methyl-5-(2-pyraziny0-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patients. Clin. Cancer Res. 6, 3870–3877 (2000).
  • Wang JS, Shen X, He X et al Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China. j Natl Cancer Inst. 91, 347–354 (1999).
  • ••Clinical trial involving modulation ofaflatoxin B1 metabolism by oltipraz.
  • Kensler TVV, Groopman JD, Sutter TR et al Development of cancer chemopreventive agents: oltipraz as a paradigm. Chem. Res. Toxicol 12, 113–126 (1999).
  • Sofowora GG, Choo EF, Mayo G et al In viva inhibition of human CYP1A2 activity by oltipraz. Cancer Chemother Pharmacol 47, 505–510 (2001).
  • Meyer DJ, Harris JM, Gilmore KS et al. Quantitation of tissue- and sex-specific induction of rat GSH transferase subunits by dietary 1,2-dithiole-3-thiones. Carcinogenesis 14, 567–572 (1993).
  • Raney KD, Meyer DJ, Ketterer B et al. Glutathione conjugation of aflatoxin B1 exo- and endo-epoxides by rat and human glutathione 5-transferases. Chem. Res. Toxicol 5, 470–478. (1992).
  • Ireland LS, Harrison DJ, Neal GE et al Molecular cloning, expression and catalytic activity of a human AKR7 member of the aldo-keto reductase superfamily: evidence that the major 2-carboxybenzaldehyde reductase from human liver is a homologue of rat aflatoxin Bl-aldehyde reductase. Biochem. 332, 21–34 (1998).
  • Loeb LA. A mutator phenotype in cancer. Cancer Res. 61, 3230–3239 (2001).
  • Moon RC, Kelloff GJ, Detrisac CJ et al Chemoprevention of OH-BBN-induced bladder cancer in mice by oltipraz, alone and in combination with 4-HPR and DFMO. Anticancer Res. 14, 5–11 (1994).
  • Pendyala L, Schwartz G, Bolanowska-Higdon Wet al. Phase Iipharmacodynamic study of N-acetylcysteindoltipraz in smokers: early termination due to excessive toxicity. Cancer Epidemiol Biomarker s Prey. 10, 269–272 (2001).
  • Talalay P, Talalay P The importance of using scientific principles in the development of medicinal agents from plants. Acad. Merl 76, 238–247 (2001).
  • Wargovich MJ, Uda N, Woods C et al Allium vegetables: their role in the prevention of cancer. Biochem. Soc. Bans. 24, 811–814 (1996).
  • Guyonnet D, Belloir C, Suschetet M et al Antimutagenic activity of organosulfur compounds from Allium is associated with phase II enzyme induction. 1VIutat. Res. 495, 135–145 (2001).
  • Lam S, MacAulay C, le Riche JC et al A randomized phase IIb trail of anethole dithiolethione in smokers with bronchial dysplasia. j Natl Cancer Inst. 94, 1001–1009 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.